Safety Tolerability and Pharmacokinetics of ALD403

This study has been completed.
Information provided by (Responsible Party):
Alder Biopharmaceuticals, Inc. Identifier:
First received: April 16, 2012
Last updated: April 25, 2013
Last verified: April 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2013
  Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)